Skip to content

R. Andrew Yockey

4 papers in the library · 84 citations · publishing 2019-2025

Papers

Sort Most recent Most cited

Reconsidering Ibogaine for the treatment of severe mental illness and substance use disorders

Journal of Medicine Surgery and Public Health August 25, 2025 R. Andrew Yockey 2 citations

Severe mental illness (SMI) and co-occurring substance use disorders (SUDs) continue to pose a major global health challenge, contributing to high rates of mortality, disability, and economic strain. Ibogaine, a naturally occurring psychoactive compound derived from the Tabernanthe iboga plant, has shown promise in easing withdrawal symptoms, reducing cravings, and improving psychiatric...

Use of psilocybin (“mushrooms”) among US adults: 2015–2018

Journal of Psychedelic Studies February 4, 2021 R. Andrew Yockey, Keith A. King 64 citations

Abstract We sought to estimate the prevalence of lifetime psilocybin use among a national sample of US adults ages 18 and older and associated demographic/substance use correlates. Pooled data from the 2015–2018 National Survey on Drug Use and Health were utilized among 168,650 individuals 18 years or older. An estimated 9.68% of individuals reported lifetime use of psilocybin. Differences were...

“Go ask Alice, when she’s 10-feet tall”: Psychosocial correlates to lifetime LSD use among a national sample of US adults

Journal of Psychedelic Studies June 26, 2019 R. Andrew Yockey, Keith A. King, Rebecca A. Vidourek 18 citations

Introduction Once thought a rarely used drug, LSD use is steadily increasing among US adults. A greater understanding of social factors and psychological determinants leading to lifetime LSD use can assist health educators and professionals in treating this growing problem. This study analyzed psychosocial factors related to LSD use among a national sample of adults. Methods A secondary data...